Antitumor effect of metformin in esophageal cancer:In vitro study

International Journal of Oncology

Volumn 42, Issue 2, 2013, Pages 517-524

  Kobayashi, Mitsuyoshi ^a   Kato, Kiyohito ^a   Iwama, Hisakazu ^a   Fujihara, Shintaro ^a   Nishiyama, Noriko ^a   Mimura, Shima ^a   Toyota, Yuka ^a   Nomura, Takako ^a   Nomura, Kei ^a   Tani, Joji ^a   Miyoshi, Hisaaki ^a   Kobara, Hideki ^a   Mori, Hirohito ^a   Murao, Koji ^a   Masaki, Tsutomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Esophageal squamous cell carcinoma; Metformin; MicroRNA

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 8; METFORMIN; MICRORNA; RETINOBLASTOMA PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY;

ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METFORMIN; MICRORNAS;

EID: 84873628875     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1722     Document Type: Article

References (25)

1. Sant M, Aareleid T, Berrino F, et al: EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 14 (Suppl 5): v61-v118, 2003.
2. Witters LA: The blooming of the French lilac. J Clin Invest 108: 1105-1107, 2001.
3. Ben Sahra I, Laurent K, Loubat A, et al: The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 27: 3576-3586, 2008.
4. Brown KA, Hunger NI, Docanto M and Simpson ER: Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase. Breast Cancer Res Treat 123: 591-596, 2010.
5. Zhou XZ, Xue YM, Zhu B and Sha JP: Effects of metformin on proliferation of human colon carcinoma cell line SW-480. Nan Fang Yi Ke Da Xue Xue Bao 30: 1935 1942, 2010 (In Chinese).
6. Hosono K, Endo H, Takahashi H, et al: Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. Mol Carcinog 49: 662-671, 2010.
7. Isakovic A, Harhaji L, Stevanovic D, et al: Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell Mol Life Sci 64: 1290-1302, 2007.
8. Zakikhani M, Dowling R, Fantus IG, Sonenberg N and Pollak M: Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 66: 10269-10273, 2006.
9. Kato K, Gong J, Iwama H, et al: The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Mol Cancer Ther 11: 549-560, 2012.
10. Masaki T, Tokuda M, Yoshida S, et al: Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis and normal liver. Int J Oncol 26: 661-671, 2005.
11. Yukimasa S, Masaki T, Yoshida S, et al: Enhanced expression of p46 Shc in the nucleus and p52 Shc in the cytoplasm of human gastric cancer. Int J Oncol 26: 905-911, 2005.
12. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
13. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
14. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
15. Anisimov VN, Berstein LM, Egormin PA, et al: Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol 40: 685-693, 2005.
16. Masaki T, Shiratori Y, Rengifo W, et al: Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 37: 534-543, 2003.
17. Zhuang Y and Miskimins WK: Cell cycle arrest in metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1. J Mol Signal 3: 18, 2008.
18. Vazquez-Martin A, Oliveras-Ferraros C, Cufi S, Martin Castillo B and Menendez JA: Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response. Cell Cycle 10: 1499-1501, 2011.
19. Liu B, Fan Z, Edgerton SM, et al: Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 8: 2031-2040, 2009.
20. Wang LW, Li ZS, Zou DW, Jin ZD, Gao J and Xu GM: Metformin induces apoptosis of pancreatic cancer cells. World J Gastroenterol 14: 7192-7198, 2008.
21. Yang YL, Xu KL, Zhou Y, Gao X and Chen LR: Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas. Chin Med J (Engl) 125: 450-454, 2012.
22. Perry JE, Grossmann ME and Tindall DJ: Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line. Prostate 35: 117-124, 1998.
23. Kitadai Y, Onogawa S, Kuwai T, et al: Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. Oncol Rep 11: 315-319, 2004.
24. Zhang Y, Liao JM, Zeng SX and Lu H: p53 downregulates Down syndrome-associated DYRK1A through miR-1246. EMBO Rep 12: 811-817, 2011.
25. Colquhoun AJ, Venier NA, Vandersluis AD, et al: Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer. Prostate Cancer Prostatic Dis: May 22, 2012 (Epub ahead of print).